The Effects of Diabetes Mellitus on Pharmacokinetics and Pharmacodynamics in Humans (original) (raw)
Adithan C, Danda D, Swaminathan RP, Indhiresan J, Shashindran CH, et al. Effect of diabetes on salivary paracetamol elimination. Clinical and Experimental Pharmacology and Physiology 15: 465–471, 1988a ArticlePubMedCAS Google Scholar
Adithan C, Danda D, Swaminathan RP, Indhiresan J, Shashindran CH, et al. Effect of type I diabetes mellitus on theophylline elimination. Medical Science Research 16: 427–428, 1988b Google Scholar
Adithan C, Sriram G, Swaminathan RP, Krishnan M, Bapna JS, et al. Effect of type II diabetes mellitus on theophylline elimination. International Journal of Clinical Pharmacology, Therapy and Toxicology 27: 258–260, 1989a CAS Google Scholar
Adithan C, Sriram G, Swaminathan RP, Shashindran CH, Bapna JS, et al. Differential effect of type I and type II diabetes mellitus on serum ampicillin levels. International Journal of Clinical Pharmacology, Therapy and Toxicology 27: 493–498, 1989b CAS Google Scholar
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983 ArticlePubMedCAS Google Scholar
Baba T, Tomiyama T, Murabayashi S, Tomiyama M, Takebe K. Enalapril pharmacokinetics in diabetic patients. Lancet 1: 226–227, 1989 ArticlePubMedCAS Google Scholar
Barry MG, Collins WCJ, Feely J. Plasma protein binding of drugs in insulin-dependent diabetes. British Journal of Pharmacology 89: 719P, 1986 Article Google Scholar
Bechtel YC, Joanne C, Grandmottet M, Bechtel PR. The influence of insulin-dependent diabetes on the metabolism of caffeine and the expression of the debrisoquin oxidation phenotype. Clinical Pharmacology and Therapeutics 44: 408–417, 1988 ArticlePubMedCAS Google Scholar
Berlin I, Grimaldi A, Bosquet F, Puech AJ. Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects. Journal of Clinical Endocrinology and Metabolism 63: 262–265, 1986 ArticlePubMedCAS Google Scholar
Bodansky HJ, Drury PL, Cudworth AG, Evans DAP. Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease. Diabetes 30: 907–910, 1981 ArticlePubMedCAS Google Scholar
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine 318: 1315–1321, 1988 ArticlePubMedCAS Google Scholar
Burrows AW, Hockaday TDR, Mann JI, Taylor JG. Diabetic dimorphism according to acetylator status. British Medical Journal 1: 208–210, 1978 ArticlePubMedCAS Google Scholar
Chase PH, Glasgow AM. Juvenile diabetes mellitus and serum lipids and lipoprotein levels. American Journal of Diseases of Children 130: 1113–1117, 1976 PubMedCAS Google Scholar
Daintith H, Stevenson IH, O’Malley K. Influence of diabetes mellitus on drug metabolism in man. International Journal of Clinical Pharmacology 13: 55–58, 1976 CAS Google Scholar
Dajani RM, Kayyali S, Saheb SE, Birbari A. A study on the physiological disposition of acetophenetidin by the diabetic man. Comparative and General Pharmacology 5: 1–9, 1974 ArticlePubMedCAS Google Scholar
Damsgaard EM. Why do elderly diabetics burden the health care system more than non-diabetics? Danish Medical Bulletin 36: 89–92, 1989 PubMedCAS Google Scholar
Della-Coletta AA, Eller MG. The bioavailability of tolazamide in diabetic patients and healthy subjects. Abstract no. PP 1301. Pharmaceutical Research 5: S–174, 1988 Google Scholar
Evans DAP, Paterson S, Francisco P, Alvarez G. The acetylator phenotypes of Saudi Arabian diabetics. Journal of Medical Genetics 22: 479–483, 1985 ArticlePubMedCAS Google Scholar
Fass RJ, Saslaw S. Clindamycin: clinical and laboratory evaluation of parenteral therapy. American Journal of the Medical Sciences 263: 369–382, 1972 Article Google Scholar
Favreau LV, Schenkman JB. Composition changes in hepatic microsomal cytochrome P-450 during onset of streptozocin-induced diabetes and during insulin treament. Diabetes 37: 577–584, 1988 ArticlePubMedCAS Google Scholar
Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Annals of Internal Medicine 98: 378–384, 1983 PubMedCAS Google Scholar
Foster KJ, Griffith AH, Dewbury K, Price CP, Wright R. Liver disease in patients with diabetes mellitus. Postgraduate Medical Journal 56: 767–772, 1980 ArticlePubMedCAS Google Scholar
Fraze E, Donner CC, Swislocki ALM, Chiou Y-AM, Chen Y-DI, et al. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. Journal of Clinical Endocrinology and Metabolism 61: 807–811, 1985 ArticlePubMedCAS Google Scholar
Fuccella LM, Tamassia V, Valzelli G. Metabolism and kinetics of the hypoglycemic agent glipizide in man — comparison with glibenclamide. Journal of Clinical Pharmacology 13: 68–75, 1973 CAS Google Scholar
Garcia G, de Vidal EL, Trujillo H. Serum levels and urinary concentrations of kanamicin, bekanamicin and amikacin (BB-K8) in diabetic children and a control group. Journal of International Medical Research 5: 322–329, 1977 PubMedCAS Google Scholar
Gatti G, Crema F, Attardo-Parrinello G, Fratino P, Aguzzi F, et al. Serum protein binding of Phenytoin and valproic acid in insulin-dependent diabetes mellitus. Therapeutic Drug Monitoring 9: 389–391, 1987 ArticlePubMedCAS Google Scholar
Gibaldi M. Biopharmaceutics and clinical pharmacokinetics, 3rd ed., pp. 206–227, Lea & Febiger, Philadelphia, 1984 Google Scholar
Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed., p. 200, Marcel Dekker, New York, 1982 Google Scholar
Grainger-Rousseau T-J, McElnay JC, Collier PS. The influence of disease on plasma protein binding of drugs. International Journal of Pharmaceutics 54: 1–13, 1989 ArticleCAS Google Scholar
Grasela DM, Wender RC, Ballas SK, Rocci ML. The effect of diabetes and sickle cell anemia on the drug metabolizing activity of erythrocyte ketone reductases. Abstract no. IIIB-2. Clinical Pharmacology and Therapeutics 45: 180, 1989 Google Scholar
Gundersen HJG. Peripheral blood flow and metabolic control in juvenile diabetes. Diabetologia 10: 225–231, 1974 ArticlePubMedCAS Google Scholar
Haggendal E, Steen B, Svanborg A. Blood flow in subcutaneous fat tissue in patients with diabetes mellitus. Acta Medica Scandinavica 187: 49–53, 1970 ArticlePubMedCAS Google Scholar
Harris MI. Prevalence of noninsulin-dependent diabetes and impaired glucose tolerance. In Harris & Hamman (Eds) Diabetes in America, NIH Publication no. 85-1468, p. VI–1, 1985 Google Scholar
Hildebrandt P, Birch K, Nielsen SL, Sestoft L. Absorption of infused insulin: kinetics and relation to subcutaneous blood flow. Abstract no. 171. Diabetologia 25: 164, 1983 Google Scholar
Hildebrandt P, Birch K, Sestoft L, Nielsen SL. Non-linear relationship between subcutaneous blood flow and insulin absorption. Abstract no. 134. Diabetologia 23: 174, 1982 Google Scholar
Isacson D, Stalhammar J. Prescription drug use among diabetics — a population study. Journal of Chronic Diseases 40: 651–660, 1987 ArticlePubMedCAS Google Scholar
Jungmann E, Seel K, Hofmann E, Scheuermann E-H, Schoffling K. Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type I diabetes mellitus. Klinische Wochenschrift 67: 1174–1181, 1989 ArticlePubMedCAS Google Scholar
Jungmann E, Walter-Schrader M-C, Haak T, Fassbinder W, Wambach G, et al. Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type I diabetes mellitus. Klinische Wochenschrift 66: 527–532, 1988 ArticlePubMedCAS Google Scholar
Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. American Journal of Cardiology 34: 29–34, 1974 ArticlePubMedCAS Google Scholar
Kazumi T, Yoshino G, Okutani T, Kato J, Kasama T, et al. Plasma lipoprotein and apolipoprotein concentrations and glycemic control during short-term treatment with nifedipine in hypertensive patients with type II diabetes mellitus. Current Therapeutic Research 46: 951–958, 1989 Google Scholar
Kearns GL, Kemp SF, Turley CP, Nelson DL. Protein binding of Phenytoin and lidocaine in pediatric patients with type I diabetes mellitus. Developmental Pharmacology and Therapeutics 11: 14–23, 1988 PubMedCAS Google Scholar
Kemp SF, Kearns GL, Turley CP. Alteration of phenytoin binding by glycosylation of albumin in IDDM. Diabetes 36: 505–509, 1987 ArticlePubMedCAS Google Scholar
Klein R, Klein BEK. Vision disorders in diabetes. In Harris & Hamman (Eds) Diabetes in America, NIH Publication no. 85-1468, p. XIII–1, 1985 Google Scholar
Koldendorf K, Bojsen J, Nielsen SL. Adipose tissue blood flow and insulin disappearance from subcutaneous tissue. Clinical Pharmacology and Therapeutics 25: 598–604, 1979 Google Scholar
Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. New England Journal of Medicine 317: 1390–1398, 1987 ArticlePubMedCAS Google Scholar
Ladero JM, Arrojo A, de Salamanca RE, Gomez M, Cano F, et al. Hepatic acetylator phenotype in diabetes mellitus. Annals of Clinical Research 14: 187–189, 1982 PubMedCAS Google Scholar
Lauritzen T, Binder C, Faber OK. Importance of insulin absorption, subcutaneous blood flow and residual beta-cell function in insulin therapy. Acta Paediatrica Scandinavica 283 (Suppl.): 81–85, 1980 ArticlePubMedCAS Google Scholar
Leinonen H, Matikainen E, Juntunen J. Permeability and morphology of skeletal muscle capillaries in type I (insulin-dependent) diabetes mellitus. Diabetologia 22: 158–162, 1982 ArticlePubMedCAS Google Scholar
Lerner PI, Weinstein L. Abnormalities of absorption of benzyl-penicillin G and sulfisoxazole in patients with diabetes mellitus. American Journal of the Medical Sciences 248: 37–51, 1964 ArticlePubMedCAS Google Scholar
Lloyd-Mostyn RH, Watkins PJ. Defective innervation of heart in diabetic autonomic neuropathy. British Medical Journal 3: 15–17, 1975 ArticlePubMedCAS Google Scholar
Longhurst PA, LaCagnin LB, Staats DA, Colby HD. Changes in hepatic drug metabolism in alloxan-diabetic male rabbits. Biochemical Pharmacology 35: 1768–1771, 1986 ArticlePubMedCAS Google Scholar
Lucas PD, Foy JM. Effects of experimental diabetes and genetic obesity on regional blood flow in the rat. Diabetes 26: 786–792, 1977 ArticlePubMedCAS Google Scholar
Madacsy L, Bokor M, Kozocsa G. Carbenicillin half-life in children with early diabetes mellitus. International Journal of Clinical Pharmacology 14: 155–158, 1976 CAS Google Scholar
Madacsy L, Bokor M, Matusovits L. Penicillin clearance in diabetic children. Acta Paediatrica Academiae Scientiarum Hungaricae 16: 139–142, 1975 PubMedCAS Google Scholar
Mattila MJ, Tiitnen H. The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients. Annales Academiae Scientiarum Fennicae 45: 423–427, 1967 CAS Google Scholar
McLaren EH, Burden AC, Moorhead PJ. Acetylator phenotypes in diabetic neuropathy. British Medical Journal 2: 291–293, 1977 ArticlePubMedCAS Google Scholar
McNamara PJ, Blouin RA, Brazzell RK. The protein binding of phenytoin, propranolol, diazepam and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum. Pharmaceutical Research 5: 261–265, 1988 ArticlePubMedCAS Google Scholar
Mereish KA, Rosenberg H, Cobby J. Glucosylated albumin and its influence on salicylate binding. Journal of Pharmaceutical Sciences 71: 235–238, 1982 ArticlePubMedCAS Google Scholar
Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712, 1973 PubMedCAS Google Scholar
Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 (Suppl. 2): 64–78, 1983 PubMed Google Scholar
Moore EW, Mitchell ML, Chalmers TC. Variability in absorption of insulin-I(131) in normal and diabetic subjects after subcutaneous and intramuscular injection. Journal of Clinical Investigation 38: 1222–1227, 1959 ArticlePubMedCAS Google Scholar
Murali KV, Adithan C, Shashindran CH, Gambhir SS, Chandrasekar S. Antipyrine metabolism in patients with diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 10: 7–13, 1983 ArticlePubMedCAS Google Scholar
Narang APS, Dutta DV, Khare AK. Impairment of drug clearance in patients with diabetes mellitus and liver cirrhosis. Indian Journal of Medical Research 85: 321–325, 1987 PubMedCAS Google Scholar
Nishio Y, Kashiwagi A, Terada M, Kida Y, Hatanaka I, et al. The effect of cardiac contractile response to epinephrine infusion in subjects with diabetes mellitus. In Shigeta et al. (Eds) Best approach to the ideal therapy of diabetes mellitus, pp. 459–462, Elsevier Science Publishers, Amsterdam, 1987 Google Scholar
Nosadini R, De Kreutzenberg S, Duner E, Iori E, Avogaro A, et al. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution based approach. Journal of Clinical Endocrinology and Metabolism 67: 551–559, 1988 ArticlePubMedCAS Google Scholar
O’Byrne S, O’Connor P, Feely J. Plasma protein binding of lignocaine and warfarin in non-insulin dependent diabetes mellitus. British Journal of Clinical Pharmacology 26: 648P, 1988 Google Scholar
O’Connell ME, Awni WM, Goodman M, Cass O, Melikian AP, et al. Bioavailability and disposition of metoclopramide after single- and multiple-dose administration in diabetic patients with gastroparesis. Journal of Clinical Pharmacology 27: 610–614, 1987 PubMed Google Scholar
O’Connor P, Feely J. Clinical pharmacokinetics and endocrine disorders: therapeutic implications. Clinical Pharmacokinetics 13: 345–364, 1987 ArticlePubMed Google Scholar
Ordonez JD, Hiatt RA. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron 51: 524–529, 1989 ArticlePubMedCAS Google Scholar
Packer M, Lee WH, Medina N, Yushak M, Kessler PD, et al. Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure. American Journal of Medicine 82: 1119–1126, 1987 ArticlePubMedCAS Google Scholar
Palumbo PJ, Melton LJ. Peripheral vascular disease and diabetes. In Harris & Hamman (Eds) Diabetes in America, NIH Publication no. 85-1468, p. XV–1, 1985 Google Scholar
Pirttiaho HI, Salmela PI, Sotaniemi EA, Pelkonen RO, Pitkanen U, et al. Drug metabolism in diabetic subjects with fatty livers. British Journal of Clinical Pharmacology 18: 895–899, 1984 ArticlePubMedCAS Google Scholar
Rao GMM, Morghom LO, Abukhris AA. Serum beta-glycosidases in diabetes mellitus. Clinical Physiology and Biochemistry 7: 161–164, 1989 PubMedCAS Google Scholar
Reinke LA, Stohs SJ, Rosenberg H. Increased aryl hydrocarbon hydroxylase activity in hepatic microsomes from streptozotocin-diabetic female rats. Xenobiotica 8: 769–778, 1979 Article Google Scholar
Rendell M, Lassek WD, Ross DA, Smith C, Kernek S, et al. A pharmaceutical profile of diabetic patients. Journal of Chronic Diseases 36: 193–202, 1983 ArticlePubMedCAS Google Scholar
Ruiz-Cabello F, Erill S. Abnormal serum protein binding of acidic drugs in diabetes mellitus. Clinical Pharmacology and Therapeutics 36: 691–695, 1984 ArticlePubMedCAS Google Scholar
Salmela PI, Sotaniemi EA, Pelkonen RO. The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus. Diabetes 29: 788–794, 1980 ArticlePubMedCAS Google Scholar
Scott AK, Cameron GA, Khir ASM, McHardy KC, Hawksworth GM. Oxazepam elimination in patients with diabetes mellitus. British Journal of Clinical Pharmacology 26: 224P, 1988 Google Scholar
Self TH, Hood J, Miller ST. Diabetes mellitus and the hypoprothrombinemic response to warfarin. Journal of the American Medical Association 239: 2239, 1978 ArticlePubMedCAS Google Scholar
Shenfield GM, McCann VJ, Tjokresetio R. Acetylator status and diabetic neuropathy. Diabetologia 22: 441–444, 1982 ArticlePubMedCAS Google Scholar
Stafford WL. Abnormality in the binding of an organic anion by diabetic serum. Lancet 1: 243–245, 1962 ArticlePubMedCAS Google Scholar
Sugimoto T, Rosansky SJ. The incidence of treated end stage renal disease in the eastern United States: 1973–1979. American Journal of Public Health 74: 14–17, 1984 ArticlePubMedCAS Google Scholar
Sugiyama H, Nakajo Y, Miyano T, Tanaka A, Uchimura I, et al. Cardiovascular reactivity and plasma renin responses to isoproterenol in diabetics with autonomic neuropathy. In Sakamoto et al. (Eds) Current topics in clinical and experimental aspects of diabetes mellitus, pp. 323–327, Elsevier Science Publishers, Amsterdam, 1985 Google Scholar
Terada M, Yasuda H, Kashawagi A, Nishio Y, Hatanaka I, et al. Sympathetic nerve dysfunction and increased heart rate response to epinephrine in diabetic patients. In Shigeta et al. (Eds) Best approach to the ideal therapy of diabetes mellitus, pp. 497–500, Elsevier Science Publishers, Amsterdam, 1987 Google Scholar
Ueda H, Sakurai T, Ota M, Nakajima A, Kamii K, et al. Disappearance rate of tolbutamide in normal subjects and in diabetes mellitus, liver cirrhosis, and renal disease. Diabetes 12: 414–419, 1963 PubMedCAS Google Scholar
Wahlin-Boll E, Aimer LO, Melander A. Bioavailability, pharmacokinetics and effects of glipizide in type II diabetics. Clinical Pharmacokinetics 7: 363–372, 1982 ArticlePubMedCAS Google Scholar
Weinstein L, Meade RH. Absorption and excretion of penicillin injected into the muscles of patients with diabetes mellitus. Nature 192: 987–988, 1961 ArticlePubMedCAS Google Scholar
Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. New England Journal of Medicine 312: 617–621, 1985 ArticlePubMedCAS Google Scholar
Yee GC, Evans WE. Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides. Pharmacotherapy 1: 55–74, 1981 PubMedCAS Google Scholar
Zysset T, Weitholtz H. Differential effect of type I and type II diabetes on antipyrine disposition in man. European Journal of Clinical Pharmacology 34: 369–375, 1988 ArticlePubMedCAS Google Scholar